Clinical Trials Directory

Trials / Terminated

TerminatedNCT01850589

Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to prove that the use of Bupropion with counseling works better than counseling alone for patients to quit smoking. The belief is that overall, there is a small percentage of patients who quit smoking all together.

Detailed description

The objective of the current investigation is to evaluate the effectiveness of an intensive verses conservative smoking cessation program in patients with peripheral arterial disease in an outpatient setting.

Conditions

Interventions

TypeNameDescription
OTHERAggressive TherapyPharmacotherapy adjuncts offered at no cost are as follows: * Chantix (varenicline) GlaxoSmithKline, * Zyban (bupropion) Pfizer,and Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline.

Timeline

Start date
2011-03-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2013-05-09
Last updated
2015-08-03
Results posted
2015-08-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01850589. Inclusion in this directory is not an endorsement.